We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
+42.86%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$216M
AUM Growth
+$39.9M
(+23%)
Cap. Flow
-$4.93M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Lyell Immunopharma
LYEL
|
+$3.04M |
| 2 |
ARTV
Artiva Biotherapeutics
ARTV
|
+$1.89M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$2.35B
| $129M | 59.53% |
4,639,304
| – | – |
|
|
ALMS
2
Alumis Inc
ALMS
$3.47B
| $45.1M | 20.85% |
4,619,803
| – | – |
|
3
Harmony Biosciences
HRMY
$1.94B
| $18.3M | 8.46% |
489,194
| – | – |
|
4
ALX Oncology
ALXO
$279M
| $11M | 5.07% |
9,699,925
| – | – |
|
|
5
Lyell Immunopharma
LYEL
$340M
| $10.4M | 4.81% |
337,697
-135,782
| -29% | -$3.04M |
|
|
ARTV
6
Artiva Biotherapeutics
ARTV
$439M
| $2.78M | 1.29% |
648,507
-500,468
| -44% | -$1.89M |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM